Cover Image

Plasma and antibody glycomic biomarkers of time to HIV rebound and viral setpoint

Saved in:

Bibliographic Details
Main Authors:	M. Abdel-Mohsen (Author), L. Giron (Author), E. Papasavvas (Author), L. Azzoni (Author), K. Mounzer (Author), J. Kostman (Author), I. Sanne (Author), C. Firnhaber (Author), Q. Liu (Author), L. Montaner (Author)
Format:	Book
Published:	Elsevier, 2019-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Distinct HIV reservoir measures correlate with defective but not intact pro-viral DNA
by: E. Papasavvas, et al.
Published: (2019)

Marine Glycomics
Published: (2022)

Baseline inducible HIV P24 is associated with viral control during interferon-α monotherapy with ART interruption
by: L.J. Montaner, et al.
Published: (2019)

Marine Glycobiology, Glycomics and Lectins
by: Ozeki, Yasuhiro
Published: (2019)

Capitalizing glycomic changes for improved biomarker-based cancer diagnostics
by: Maria Luísa S. Silva
Published: (2023)

Chapter Perspectives in Glycomics and Lectin Engineering
by: Tkac, Jan
Published: (2014)

Mass Spectrometry Imaging for Glycome in the Brain
by: Md. Mahmudul Hasan, et al.
Published: (2021)

OP 7.3 - 00139 Pre-treatment Interruption Plasma Metabolites and Glycans Correlate with Time to HIV Rebound and Reservoir Size in ACTG A5345
by: L.B. Giron, et al.
Published: (2022)

PP 2.12 - 00153 eCD4-Ig-DNA Decreased HIV Reservoir and Delayed Viral Rebound Through Fc Mediated Functions in BLT Humanized Mice
by: Z. Yuan, et al.
Published: (2022)

Oxygen-Dependent Changes in the N-Glycome of Murine Pulmonary Endothelial Cells
by: Akos Tiboldi, et al.
Published: (2021)

11 Murine model to predict viral rebound in HIV+ allotransplanted subjects
by: Maria Salgado, et al.
Published: (2017)

Lectin histochemical findings of modified glycome of corneal structural components in experimental hypothyroidism
by: M. B. Shchur, et al.
Published: (2019)

Effect of natural killer cells on viral rebound in HIV-1-infected humanized mice
by: J. Kim, et al.
Published: (2019)

Intact and replication-competent reservoir virus populations differ from each other and rebound plasma viruses
by: K. Bar, et al.
Published: (2019)

Differential viral rebound between lymph node and colon after treatment interruption in SHIV-infected rhesus macaques
by: D.C. Hsu, et al.
Published: (2017)

A phase 2 trial to evaluate the effects of 3BNC117 in addition to antiretroviral therapy on the latent reservoir and viral rebound
by: J. Lorenzi, et al.
Published: (2017)

OA4-1 Combined IL-21 and IFNα treatment limits residual inflammation, viral persistence and delays viral rebound in SIV-infected rhesus macaques
by: L. Micci, et al.
Published: (2017)

Viral load and rebound in children with coronavirus disease 2019 during the first outbreak in Daegu city
by: Mi Ae Chu, et al.
Published: (2021)

Changes in access to viral load testing, incidence rates of viral load suppression and rebound following the introduction of the 'universal test and treat' guidelines in Cameroon: A retrospective follow-up analysis.
by: C E Bekolo, et al.
Published: (2024)

Changes in access to viral load testing, incidence rates of viral load suppression and rebound following the introduction of the 'universal test and treat' guidelines in Cameroon: A retrospective follow-up analysis
by: C. E. Bekolo, et al.
Published: (2024)

Viral rebound and safety of nirmatrelvir/ritonavir for lung-transplant recipients infected with SARS-CoV-2
by: Hui Li, et al.
Published: (2023)

4 Post-treatment control or treated controllers? The impact of ART on time to viral rebound in recent seroconverters
by: G.E. Martin, et al.
Published: (2016)

Delay in viral rebound with TLR7 agonist, N6-LS and PGT121 in SHIV-infected macaques
by: D. Hsu, et al.
Published: (2019)

Cleaving HIV-1 provirus from ART-suppressed patient-derived resting CD4 T Cells using Cpf1/crRNA-array ribonucleotide protein packaged by CD4-targeting lentivirus-like particle
by: W. Hu, et al.
Published: (2019)

Marked variation in the susceptibility of HIV-1 to type 1 interferon inhibition during early, late and rebound infection
by: M. Gondim, et al.
Published: (2019)

Early adiposity rebound: predictors and outcomes
by: Alessandra Li Pomi, et al.
Published: (2024)

Rebound pain: Undesired, yet unexplored
by: Pradeep Bhatia, et al.
Published: (2022)

The effects of rebound therapy and aerobic training on aerobic capacity, plasma endotheline level and the quality of life in male patients with asthma
by: Morteza Sadeghi, et al.
Published: (2012)

α4β7-blockade delays viral rebound in SHIV infected macaques treated with a combination of HIV bNAbs
by: E. Martinelli
Published: (2019)

Partial control of viral rebound with a Rev-dependent lentiviral vector carrying HSV-tk gene in SIV-infected rhesus macaques
by: Y. Wu, et al.
Published: (2017)

Bispecific antibodies for viral immunotherapy
by: Elisabeth K. Nyakatura, et al.
Published: (2017)

VIRAL ANTIBODIES IN PRESCHOOL CHILDREN
by: S. Saidi
Published: (1974)

VIRAL ANTIBODIES IN PRESCHOOL CHILDREN
by: S. Saidi
Published: (1974)

PP 7.2 - 00006 Acceptability of Home-Based Blood Collection Device for Viral Load Testing in HIV Cure Trials with Analytical Treatment Interruptions
by: K. Dubé, et al.
Published: (2022)

PP 4.11 - 00126 Autologous Neutralizing Antibodies Increase with Early Antiretroviral Therapy and Shape HIV Rebound after Treatment Interruption
by: E. Esmaeilzadeh, et al.
Published: (2022)

Analysis of rebounded balls in a team handball match
by: Ante Burger, et al.
Published: (2013)

Beta-blocker Rebound Phenomenon in an Adolescent with Graves' Disease
by: Ahmet Anık
Published: (2022)

Early Adiposity Rebound and Obesity in Children with Congenital Hypothyroidism
by: Shou-Yen Chen, et al.
Published: (2013)

Rebound Thymic Hyperplasia after Chemotherapy in Children with Lymphoma
by: Chih-Ho Chen, et al.
Published: (2017)

Effect of functional ankle instability on rebound drop jump
by: Naruto Yoshida, et al.
Published: (2012)